BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36067955)

  • 21. A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.
    Moqbel HA; ElMeshad AN; El-Nabarawi MA
    Drug Deliv; 2016 Oct; 23(8):2998-3007. PubMed ID: 26828616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of the impact of lubrication on tablet compactibility.
    Puckhaber D; Finke JH; David S; Serratoni M; Zafar U; John E; Juhnke M; Kwade A
    Int J Pharm; 2022 Apr; 617():121557. PubMed ID: 35134481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach of external lubrication in a rotary tablet press using electrostatics.
    Zimmermann M; Michel F; Bartsch J; Thommes M
    Drug Dev Ind Pharm; 2022 Dec; 48(12):737-744. PubMed ID: 36620915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic evaluation of common lubricants for optimal use in tablet formulation.
    Paul S; Sun CC
    Eur J Pharm Sci; 2018 May; 117():118-127. PubMed ID: 29432807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets.
    Vlad RA; Antonoaea P; Todoran N; Muntean DL; Rédai EM; Silași OA; Tătaru A; Bîrsan M; Imre S; Ciurba A
    Saudi Pharm J; 2021 Sep; 29(9):1029-1042. PubMed ID: 34588849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of properties of tablets and energy profile of compaction of two spray-dried lactoses.
    Muzíková J; Sináglová P
    Acta Pol Pharm; 2013; 70(1):129-35. PubMed ID: 23610968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
    Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
    Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Press chamber coating as external lubrication for high speed rotary presses: lubricant spray rate optimization.
    Jahn T; Steffens KJ
    Drug Dev Ind Pharm; 2005 Dec; 31(10):951-7. PubMed ID: 16316850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of Dispersion Kinetics of Particulate Lubricants and their Effect on the Mechanical Strength of MCC Tablets.
    Puckhaber D; Kwade A; Finke JH
    Pharm Res; 2023 Oct; 40(10):2479-2492. PubMed ID: 37752367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hexagonal boron nitride as a tablet lubricant and a comparison with conventional lubricants.
    Uğurlu T; Turkoğlu M
    Int J Pharm; 2008 Apr; 353(1-2):45-51. PubMed ID: 18160235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commercial scale validation of a process scale-up model for lubricant blending of pharmaceutical powders.
    Kushner J; Schlack H
    Int J Pharm; 2014 Nov; 475(1-2):147-55. PubMed ID: 25152166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of compaction tools and parameters on critical quality attributes of high drug load minitablets.
    Loo SJ; Lim CY; Heng PWS; Chan LW
    Int J Pharm; 2024 Mar; 652():123806. PubMed ID: 38220119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.
    Hobbs D; Karagianis J; Treuer T; Raskin J
    Drugs R D; 2013 Dec; 13(4):281-8. PubMed ID: 24170256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets.
    Soh JL; Grachet M; Whitlock M; Lukas T
    Pharm Dev Technol; 2013 Feb; 18(1):172-85. PubMed ID: 22582882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the granulation technique and starting material properties on the lubricating effect of granular magnesium stearate.
    Johansson ME
    J Pharm Pharmacol; 1985 Oct; 37(10):681-5. PubMed ID: 2867134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Orodispersible Mini Tablets of Enalapril Maleate by Direct Compression for Pediatric Patients.
    Ortega CA; Favier LS; Cianchino VA; Cifuente DA
    Curr Drug Deliv; 2020; 17(6):505-510. PubMed ID: 32384031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the compaction process and the properties of tablets made of a new co-processed starch excipient.
    Mužíková J; Eimerová I
    Drug Dev Ind Pharm; 2011 May; 37(5):576-82. PubMed ID: 21469946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downstream processing of amorphous solid dispersions into orodispersible tablets.
    Kokott M; Klinken S; Breitkreutz J; Wiedey R
    Int J Pharm; 2023 Jan; 631():122493. PubMed ID: 36528189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.